Estimating the global demand curve for a leishmaniasis vaccine: a generalisable approach based on global burden of disease estimates

HIGHLIGHTS

• who: Sakshi Mohan et al. from the Center for Health Economics (CHE), University of York, York, United Kingdom, MMGH Consulting have published the article: Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates, in the Journal: (JOURNAL) of August/29,/2021
• what: The study seeks to bridge this information gap by providing a generalisable approach to estimating the commercial and public health value of a vaccine in development relying primarily on publicly available Global Burden of Disease (GBD) data. General approach This study assesses the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.